Table 2. Comparison of the patients who died and who are alive.

NLR: neutrophil to lymphocyte ratio; SII: systemic immune-inflammation index

	Group 1 (Dead, N=12)		Group 2 (Alive, N=34)	p-value
Gender (Male)	7 (58.8%)		18 (52.9%)	0.747
Age (months)	71.74 (22.16-169.05)		52.48 (4.1-134.1)	0.140
Ultrasonography (≤5 cm)	7 (58.3 %)		17 (50%)	0.619
CT (≤5 cm)	5 (41.7%)		16 (47.1%)	0.747
PET (SUV max≤2.6)	3 (12%)		12 (75%)	0.136
Histopathology	differentiated	-	5 (14.7%)	0.201
	Undifferentiated + poorly differentiated	3 (25%)	15 (44%)
	Unknown	8 (66.7%)	12 (35.3%)
	Intermixed	1 (8.3%)	2 (5.8%)
Stage (Early 1,2)	0 (0%)		7 (20.6%)	0.708
Metastasis (Present)	9 (75%)		20 (58.8%)	0.318
Lymph node involvement (Present)	3 (25%)		8 (23.5%)	0.667
Neoadjuvant chemotherapy (Present)	12 (100%)		24 (70.6%)	0.034
Lymphocyte number	4027 (1880-6170)		4518 (940-7630)	0.444
Neutrophil number	4428 (2520-6380)		4229 (1170-8430)	0.294
Platelet number	297.33 (22-890)		359.1 (33-664)	0.406
NLR	2.71 (1.22-4.1)		1.7 (0.16-5.1)	0.02
SII	677.8 (215-1322)		294.6 (69.49-799.1)	0.012
Ferritin (ng/ml)	249 (91.6-384)		219.6 (9-787)	0.412